Allyson A. Arana

Allyson A. Arana

Auto-generated profile, based on publicly available information

Allyson A. Arana

En Route Care Research Center, United States Army Institute of Surgical Research , JBSA Fort Sam, TX 78234

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Merrill-Palmer Quarterly
Verified
Journal Article
Closed access
AAAllyson A. Arana
Allyson A. Arana
EBErin Q. Boyd
Erin Q. Boyd
MGMaria Guarneri-White
Maria Guarneri-White
PIPriya Iyer-Eimerbrink
Priya Iyer-Eimerbrink
ADAngela Liegey Dougall
Angela Liegey Dougall
LPLauri Jensen-Campbell, PhD
Lauri Jensen-Campbell, PhD

26 February 2021 in Military Medicine
Verified
Journal Article
Open access
PDF file
JMJoseph K Maddry
Joseph K Maddry
AAAllyson A Arana
Allyson A Arana
AMAlejandra G Mora
Alejandra G Mora
CPCrystal A Perez
Crystal A Perez
JCJulie E Cutright
Julie E Cutright
VBVikhyat S Bebarta
Vikhyat S Bebarta
Introduction: The U.S. military currently utilizes unmanned aerial vehicles (UAVs) for reconnaissance and attack missions; however, as combat environment technology advances, there is the increasing likelihood of UAV utilization in prehospital aeromedical evacuation. Although some combat casualties require life-saving interventions (LSIs) during medical evacuation, many do not. Our objective was to describe patients transported from the point of injury to the first level of care and characterize differences between patients who received LSIs en route and those who did not. Materials and Methods: We conducted a retrospective review of the records of traumatically injured patients evacuated between January 2011 and March 2014. We compared patient characteristics, complications, and outcomes based on whether they had an LSI performed en route (LSI vs. No LSI). We also constructed logistic regression models to determine which characteristics predict uneventful flights (no en route LSI or complications). Results: We examined 1,267 patient records; 47% received an LSI en route. Most patients (72%) sustained a blast injury and injuries to the extremities and head. Over 78% experienced complications en route; the LSI group had higher rates of complications compared to the No LSI group. Logistic regression showed that having a blunt injury or the highest abbreviated injury scale (AIS) severity score in the head/neck region are significant predictors of having an uneventful flight. Conclusion: Approximately half of casualties evaluated in our study did not receive an LSI during transport and may have been transported safely by UAV. Having a blunt injury or the highest AIS severity score in the head/neck region significantly predicted an uneventful flight.

13 June 2024 in Military Medicine
Verified
Journal Article
Open access
PDF file
RNRyan K Newberry
Ryan K Newberry
RPR Madelaine Paredes
R Madelaine Paredes
EBEd B G Barnard
Ed B G Barnard
TRTheodore T Redman
Theodore T Redman
AAAllyson A Arana
Allyson A Arana
JRJason M Rall
Jason M Rall
Uncontrolled torso hemorrhage is the primary cause of potentially survivable deaths on the battlefield. Zone 1 Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA), in conjunction with damage control resuscitation, may be an effective management strategy for these patients in the prehospital or austere phase of their care. However, the effect of whole blood (WB) transfusion during REBOA on post-occlusion circulatory collapse is not fully understood. Yorkshire male swine (n = 6 per group, 70–90 kg) underwent a 40% volume-controlled hemorrhage. After a 10-minute hemorrhagic shock period, a REBOA balloon was inflated in Zone 1. Fifteen minutes after inflation, 0, 1, or 3 units (450 mL/unit) of autologous WB was infused through the left jugular vein. Thirty minutes after initial balloon inflation, the balloon was deflated slowly over 3 minutes. Following deflation, normal saline was administered (up to 3,000 mL) and swine were observed for 2 hours. Survival (primary outcome), hemodynamics, and blood gas values were compared among groups. Statistical significance was determined by log-rank test, one-way ANOVA, and repeated measures ANOVA. Survival rates were comparable between groups (P = .345) with 66% of control, 33% of the one-unit animals, and 50% of the 3-unit animals survived until the end of the study. Following WB infusion, both the 1-unit and the 3-unit groups had significantly higher blood pressure (P < .01), pulmonary artery pressure (P < .01), and carotid artery flow (P < .01) compared to the control group. WB transfusion during Zone 1 REBOA was not associated with increased short-term survival in this large animal model of severe hemorrhage. We observed no signal that WB transfusion may mitigate post-occlusion circulatory collapse. However, there was evidence of supra-normal blood pressures during WB transfusion.